Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial [Phase 2]
Phase 2 randomized controlled trial evaluating an empowerment-based intervention designed to reduce helplessness and enhance recovery in peo…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Assertive Community Treatment With CBT and SST for Schizophrenia [NA]
This document reports the completion of a clinical trial evaluating assertive community treatment combined with cognitive behavioral therapy…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Cognitive Remediation and Functional Skills Training in Schizophrenia [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating cognitive remediation and functional skills training for schizophrenia has completed. The study a…
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Effects of Ketamine and Risperidone on Cognition [Phase 4]
A Phase 4 trial assessed the cognitive effects of ketamine and risperidone in healthy volunteers and individuals with schizophrenia and has …
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Safety and Efficacy of Zicronapine in Patients With Schizophrenia [Phase 3]
This Phase 3 trial evaluated the safety and efficacy of Zicronapine in patients with schizophrenia and is completed. The available excerpt d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Efficacy of Lu 31-130 in Patients With Schizophrenia [Phase 2]
This clinical trial update reports the efficacy results of Lu 31-130 in patients with schizophrenia in a Phase 2 study.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Efficacy of Lu 31-130 in Patients With Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating Lu 31-130 for schizophrenia has completed, reporting efficacy findings.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill [NA]
A completed clinical trial evaluating contingency management for stimulant use disorder in individuals with severe mental illness.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia [Phase 2]
Phase 2 efficacy study evaluating Lu AE58054 as augmentation therapy in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia [Phase 4]
A Phase 4 safety study of the antipsychotic Sertindole for schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis [NA]
This ClinicalTrials.gov entry reports a completed study on multi-disciplinary treatment for patients experiencing a first episode of psychos…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder [Phase 1]
Phase 1 study evaluating RO4917838 on biomarker measures of cognitive dysfunction in participants with schizophrenia and schizoaffective dis…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of RO5545965 in schizophrenia patients taking risperidone has comple…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia [Phase 2]
Phase 2 study of RO4917838 (Bitopertin) in patients with acute exacerbation of schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) [Phase 3]
Phase 3 trial of Bitopertin (RO4917838) in schizophrenia has completed. The update reports the study status without detailing results.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) [Phase 3]
Phase 3 clinical trial update for Bitopertin (RO4917838) in patients with persistent, predominant negative symptoms of schizophrenia; the st…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: tDCS & Auditory Hallucinations in Schizophrenia [NA]
This clinical trial update reports termination of a study evaluating transcranial direct current stimulation for auditory hallucinations in …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305) [Phase 3]
This update describes a Phase 3 study of bitopertin (RO4917838) for sub-optimally controlled schizophrenia symptoms. The trial status is com…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Specialized Treatment Early in Psychosis (STEP) [NA]
This document reports a completed STEP trial evaluating specialized treatment early in psychosis, with results posted in 2016. The study foc…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Cognitive Behavior Therapy and Work Outcome [NA]
A completed trial assessed cognitive behavior therapy and work outcomes in schizophrenia, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants [Phase 1]
Phase 1 safety, tolerability and pharmacokinetic study of TAK-063 in participants with stable schizophrenia and healthy volunteers has compl…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: CHANGE -it is About Life [Phase 3]
A Phase 3 clinical trial named CHANGE - it is About Life has completed. It covers schizophrenia and metabolic syndrome.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) [Phase 3]
A long-term safety Phase 3 study of ALKS 9072/ALKS 9070 in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia [NA]
A completed clinical trial evaluated the effect of repetitive transcranial magnetic stimulation on resting-state brain activity in individua…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen [NA]
This update notes the completed status of a substudy within the OPTIMISE trial at Copenhagen, focusing on optimization of treatment and mana…